Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Several studies have shown a relationship between vitamin D and migraine, including the association between decreased serum 25‐hydroxyvitamin D in patients with migraine and the positive effects of vitamin D supplementations in the therapy of this disease.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D receptor and binding protein genes variants in patients with migraine

Study design awaiting verification · Annals of Clinical and Translational Neurology · 2023

Original publication title

Vitamin D receptor and binding protein genes variants in patients with migraine

Elena García‐Martín; Santiago Navarro‐Muñoz; Pedro Ayuso; Christopher Rodríguez; Mercedes Serrador; Hortensia Alonso‐Navarro; Marisol Calleja; Silvina Espada‐Rubio; Francisco Navacerrada; Laura Turpín‐Fenoll; Marta Recio‐Bermejo; Rafael García‐Ruiz; Jorge Millán‐Pascual; José Francisco Plaza‐Nieto; Esteban García‐Albea; José A.G. Agúndez; Félix Javier Jiménez‐Jiménez

© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

In summary, the results of the current study suggest a lack of association between common SNVs in the VDR and GC gene and the risk of developing migraine. The possible relationship between VDR rs731236 and the triggering of migraine episodes with ethanol deserves future studies.

An extract from the source publication. Read it in context.

At a glance

Abstract: Background/Objectives

Several studies have shown a relationship between vitamin D and migraine, including the association between decreased serum 25‐hydroxyvitamin D in patients with migraine and the positive effects of vitamin D supplementations in the therapy of this disease. Two single‐nucleotide variants (SNVs) vitamin D receptor (VDR) gene, VDR rs2228570, and VDR rs731236 have shown an association with migraine risk in a previous case: control association study, while an exome sequencing study identified a rare variant in GC vitamin D binding protein gene.

This study aims to look for the association between several common variants in these two genes and the risk for migraine.

Source: Background/Objectives

Abstract: What methods does the paper describe?

We genotyped 290 patients diagnosed with migraine and 300 age‐matched controls using specific TaqMan assays for VDR rs2228570, VDR rs731236, VDR rs7975232, VDR rs739837, VDR rs78783628, GC rs7041, and GC rs4588 SNVs.

Source: Methods

Abstract: Results

We did not find an association between these SNVs and the risk for migraine. None of these SNVs were related to the positivity of a family history of migraine or with the presence of aura. The VDR rs731236A allele showed a significant association with the triggering of migraine attacks by ethanol (Pc = 0.007).

Source: Results

Abstract: Conclusions

In summary, the results of the current study suggest a lack of association between common SNVs in the VDR and GC gene and the risk of developing migraine. The possible relationship between VDR rs731236 and the triggering of migraine episodes with ethanol deserves future studies.

Source: Conclusions
Authors’ abstract

Abstract

Background/Objectives

Several studies have shown a relationship between vitamin D and migraine, including the association between decreased serum 25‐hydroxyvitamin D in patients with migraine and the positive effects of vitamin D supplementations in the therapy of this disease. Two single‐nucleotide variants (SNVs) vitamin D receptor (VDR) gene, VDR rs2228570, and VDR rs731236 have shown an association with migraine risk in a previous case: control association study, while an exome sequencing study identified a rare variant in GC vitamin D binding protein gene.

This study aims to look for the association between several common variants in these two genes and the risk for migraine.

Methods

We genotyped 290 patients diagnosed with migraine and 300 age‐matched controls using specific TaqMan assays for VDR rs2228570, VDR rs731236, VDR rs7975232, VDR rs739837, VDR rs78783628, GC rs7041, and GC rs4588 SNVs.

Results

We did not find an association between these SNVs and the risk for migraine. None of these SNVs were related to the positivity of a family history of migraine or with the presence of aura. The VDR rs731236A allele showed a significant association with the triggering of migraine attacks by ethanol (Pc = 0.007).

Conclusions

In summary, the results of the current study suggest a lack of association between common SNVs in the VDR and GC gene and the risk of developing migraine. The possible relationship between VDR rs731236 and the triggering of migraine episodes with ethanol deserves future studies.

Publication and source details

Original title: Vitamin D receptor and binding protein genes variants in patients with migraine

Elena García‐Martín; Santiago Navarro‐Muñoz; Pedro Ayuso; Christopher Rodríguez; Mercedes Serrador; Hortensia Alonso‐Navarro; Marisol Calleja; Silvina Espada‐Rubio; Francisco Navacerrada; Laura Turpín‐Fenoll; Marta Recio‐Bermejo; Rafael García‐Ruiz; Jorge Millán‐Pascual; José Francisco Plaza‐Nieto; Esteban García‐Albea; José A.G. Agúndez; Félix Javier Jiménez‐Jiménez

Annals of Clinical and Translational Neurology · 2023

* Correspondence
José A.G. Agúndez, Universidad de Extremadura, University Institute of Molecular Pathology Biomarkers, Cáceres 10071, Spain. Tel/Fax: +34 619215370; E‐mail: jagundez@unex.es
Félix Javier Jiménez‐Jiménez, Section of Neurology, Hospital Universitario del Sureste. Ronda del Sur 10, Arganda del Rey, Madrid E28500, Spain. Tel/Fax: +34 610657292; E‐mail: fjavier.jimenez@salud.madrid.org; felix.jimenez@sen.es
© 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.Instituto de Salud Carlos III 10.13039/501100004587PI18/00540PI21/01683Junta de Extremadura, Mérida, SpainGR21073IB20134This work was funded by Instituto de Salud Carlos III 10.13039/501100004587 grants PI18/00540 and PI21/01683; Junta de Extremadura, Mérida, Spain grants GR21073 and IB20134.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T06:04:20.947046+00:00

DOI: 10.1002/acn3.51872 · PMC10578880